Picture of Gubra A/S logo

GUBRA — Gubra A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapFalling Star

Brief: Abbvie And Gubra Announce License Agreement

March 3 (Reuters) - Gubra A/S GUBRA.CO:

ABBVIE AND GUBRA ANNOUNCE LICENSE AGREEMENT TO DEVELOP AN AMYLIN ANALOG FOR THE TREATMENT OF OBESITY

Source text: ID:nMFN9ytvFw

Further company coverage: GUBRA.CO

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Gubra A/S

See all news